logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-9. Last 12 months prevalence of ecstasy use among all adults (aged 15–64), young adults (aged 15–34) and youth (aged 15–24)

Part (ii) Males aged 15–24 in countries with high prevalence rates

 
 
CountryAll adults (15 to 64 yrs)Youth males (15 to 24 yrs)
Related links:
LT (2008)1.03.1
EE (2008)1.23.3
UK (E&W) (2011/12)1.44.3
PL (2010)1.56.7
CZ (2011)1.65.7
Statistical bulletin 2008: Figure GPS-9 part (ii)
Statistical bulletin 2009: Figure GPS-9 part (ii)
Statistical bulletin 2010: Figure GPS-9 part (ii)
Statistical bulletin 2011: Figure GPS-9 part (ii)
Statistical bulletin 2012: Figure GPS-9 part (ii)
See also Tables GPS-2 part i, GPS-2 part ii and GPS-2 part iii
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Data are from the most recent national surveys available in each country.

The age range is from between 15 and 18 years to between 59 and 64 years. Variations in age ranges may slightly influence disparities between countries.

Czech Republic: 2011; 15–64 yrs n = 901; 15–34 yrs n = 361; 15–24 yrs n = 157

Estonia 2008; 15–64 yrs n = 1401; 15–34 yrs n = 545; 15–24 yrs n = 243

Lithuania: 2008; 15–64 yrs n = 4777; 15–34 yrs n = 2152; 15–24 n = 1165

Poland: 2010; 15–64 yrs n = 5782; 15–34 yrs n = 3201; 15–24 yrs n = 1736

UK (E&W): 2011/12; 16–59 yrs n = 26663; 16–34 yrs n = 9691; 16–24 yrs n = 3534

Sources:

Reitox national reports 2012, taken from population surveys, reports or scientific articles.

Country All adults (15 to 64 yrs) Youth males (15 to 24 yrs)
LT (2008) 1.0 3.1
EE (2008) 1.2 3.3
UK (E&W) (2011/12) 1.4 4.3
PL (2010) 1.5 6.7
CZ (2011) 1.6 5.7

gpsfig9b

 

Page last updated: Tuesday, 30 April 2013